KEY FINDINGS
The Europe advanced wound care management market is evaluated to register a CAGR of 11.53% over the estimated period. Key propelling factors like the strong presence of leading players, the increasing demand for wound care products, and the rising patient awareness towards advanced wound care treatment and management predominantly fuel the market growth of the region.
MARKET INSIGHTS
The Europe advanced wound care management market growth assessment entails evaluating Germany, Russia, the United Kingdom, Poland, Italy, Belgium, France, and the rest of Europe. According to an article published in 2019, the number of urogynecological (UI) surgeries performed in Poland increased between 2011 and 2015. Subsequently, it continued to remain at a relatively stable level. While a similar trend was also recorded for tape procedures, the popularity of colposuspension considerably declined. Moreover, owing to the aging population in the country, the demand for treating pelvic organ prolapse (POP) poses significant challenges for medical professionals as well as the public health care system in general.
According to the statistics issued by the OECD, the number of cataract surgeries performed in Italy accounted for 931.2 per 100,000 people in 2017. The increasing number of surgeries in the country plays a vital role in augmenting the advanced wound care management market. Furthermore, the aging population, in addition to the demand for improved life quality, the acceptance of innovative technologies, and effective reimbursement practices, further drive the adoption of minimally invasive surgeries, thereby increasing the demand for advanced wound care products. Hence, these factors are set to facilitate the market’s growth in Europe.
COMPETITIVE INSIGHTS
Some of the eminent companies operating in the market are Medtronic PLC, Johnson & Johnson, Smith & Nephew PLC, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION
3.1.2. INCIDENCE OF CHRONIC DISEASES
3.1.3. ADVANCEMENT IN TECHNOLOGY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED WOUND CARE PRODUCTS
3.2.2. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON ADVANCED WOUND CARE MANAGEMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. THERAPY DEVICES
5.2. EXUDATE MANAGEMENT
5.3. INFECTION MANAGEMENT
5.4. ACTIVE WOUND CARE
6. MARKET BY APPLICATION
6.1. CHRONIC WOUNDS
6.2. ACUTE WOUNDS
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. COMMUNITY HEALTH SERVICE CENTERS
8. GEOGRAPHICAL ANALYSIS
8.1. EUROPE
8.2. MARKET SIZE & ESTIMATES
8.3. KEY GROWTH ENABLERS
8.4. KEY CHALLENGES
8.5. KEY PLAYERS
8.6. COUNTRY ANALYSIS
8.6.1. GERMANY
8.6.2. FRANCE
8.6.3. UNITED KINGDOM
8.6.4. ITALY
8.6.5. RUSSIA
8.6.6. BELGIUM
8.6.7. POLAND
8.6.8. REST OF EUROPE
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. 3M COMPANY
9.2.2. B BRAUN MELSUNGEN AG
9.2.3. COLOPLAST
9.2.4. CONVATEC GROUP PLC
9.2.5. ESSITY AB
9.2.6. HARTMANN GROUP
9.2.7. HOLLISTER INCORPORATED
9.2.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9.2.9. JOHNSON & JOHNSON (ETHICON INC)
9.2.10. MEDTRONIC PLC
9.2.11. MEDLINE INDUSTRIES INC
9.2.12. MOLNLYCKE HEALTH CARE AB
9.2.13. ORGANOGENESIS HOLDINGS INC
9.2.14. SMITH & NEPHEW PLC
1. 3M COMPANY
2. B BRAUN MELSUNGEN AG
3. COLOPLAST
4. CONVATEC GROUP PLC
5. ESSITY AB
6. HARTMANN GROUP
7. HOLLISTER INCORPORATED
8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9. JOHNSON & JOHNSON (ETHICON INC)
10. MEDTRONIC PLC
11. MEDLINE INDUSTRIES INC
12. MOLNLYCKE HEALTH CARE AB
13. ORGANOGENESIS HOLDINGS INC
14. SMITH & NEPHEW PLC